Tao Zhu

51 años

Consumer Services

Health Technology

Perfil

Tao Zhu fundó CanSino Biologics, Inc. Es Director Ejecutivo, CSO y Director General Adjunto de esta empresa. También forma parte del consejo de administración de Beijing Mabworks Biotech Co. En su anterior carrera ocupó el puesto de Científico Investigador Senior en Sanofi. El Dr. Zhu se doctoró en la Universidad Carnegie Mellon, se licenció y se graduó en la Universidad de Tsinghua y se doctoró en la Universidad de Pittsburgh.

Cargos activos de Tao Zhu

Empresas	Cargo	Inicio
CANSINO BIOLOGICS INC.	Founder	13/01/2009
Beijing Mabworks Biotech Co., Ltd. Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China.	Director/Board Member	26/03/2020

Todos los cargos activos de Tao Zhu

Antiguos cargos conocidos de Tao Zhu.

Empresas	Cargo	Fin
SANOFI	Corporate Officer/Principal	01/01/2009

Ver el detalle de la experiencia de Tao Zhu.

Formación de Tao Zhu.

Carnegie Mellon University	Doctorate Degree
University of Pittsburgh	Doctorate Degree
Tsinghua University	Undergraduate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Tao Zhu.

Relaciones

100 +

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	2
SANOFI	Health Technology
CANSINO BIOLOGICS INC.	Health Technology

Empresas privadas	1
Beijing Mabworks Biotech Co., Ltd. Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China.	Health Technology